Published in Immunology on October 01, 1997
Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut (2000) 4.32
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest (2008) 2.23
Regulation of inflammation by short chain fatty acids. Nutrients (2011) 2.15
Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes. PLoS Pathog (2014) 1.59
Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun (2004) 1.24
Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol (2002) 1.17
The microbiome and regulation of mucosal immunity. Immunology (2014) 1.10
Regulation of immune responses by histone deacetylase inhibitors. ISRN Hematol (2012) 0.90
n3 PUFAs reduce mouse CD4+ T-cell ex vivo polarization into Th17 cells. J Nutr (2013) 0.87
The bowel microbiota and inflammatory bowel diseases. Int J Inflam (2010) 0.87
Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis. Nutr Neurosci (2014) 0.84
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis. World J Gastroenterol (2014) 0.82
Eicosanoid modulation by the short-chain fatty acid n-butyrate in human monocytes. Immunology (2013) 0.81
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol (2016) 0.80
Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease. Sci Rep (2016) 0.77
Gut Function-Enhancing Properties and Metabolic Effects of Dietary Indigestible Sugars in Rodents and Rabbits. Nutrients (2015) 0.75
Human monocytes downregulate innate response receptors following exposure to the microbial metabolite n-butyrate. Immun Inflamm Dis (2017) 0.75
A cell culture model for T lymphocyte clonal anergy. Science (1990) 9.86
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med (1991) 8.78
Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut (1987) 6.61
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med (1987) 5.48
The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol (1990) 4.03
B70 antigen is a second ligand for CTLA-4 and CD28. Nature (1993) 3.57
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med (1994) 3.24
Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol (1991) 3.12
Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol (1987) 2.85
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med (1993) 2.71
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest (1992) 2.51
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med (1992) 2.42
Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol (1991) 2.39
Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol (1990) 2.37
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med (1994) 2.14
Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol (1991) 2.03
Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res (1994) 1.85
Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol (1995) 1.74
Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60
Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer (1995) 1.54
The role of cell division in the induction of clonal anergy. Immunol Today (1992) 1.46
Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J Exp Med (1988) 1.45
Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol (1990) 1.31
Surface proteins involved in T cell costimulation. J Leukoc Biol (1994) 1.09
Th1 cell anergy and blockade in G1a phase of the cell cycle. J Immunol (1993) 1.07
Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J Immunol (1992) 1.06
Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. Cancer Lett (1994) 1.03
Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction. J Immunol (1994) 1.02
B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J Immunol (1996) 1.01
B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro. J Immunol (1996) 0.99
Differential regulation of human T cell responsiveness by mucosal versus blood monocytes. Eur J Immunol (1996) 0.91
Effect of sodium butyrate on lymphocyte activation. J Exp Med (1976) 0.88
Sodium butyrate delays neutrophil apoptosis: role of protein biosynthesis in neutrophil survival. Br J Haematol (1996) 0.88
Induction of the lytic viral cycle in Epstein Barr virus carrying Burkitt lymphoma lines is accompanied by increased expression of major histocompatibility complex molecules. Immunol Lett (1993) 0.87
Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles. J Immunol (1994) 0.85
Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol (1996) 0.85
Chemical inducers of differentiation in Friend leukaemia cells inhibit lymphocyte mitogenesis. Nature (1980) 0.84
Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. J Immunol (1994) 0.84
The primary alloresponse of human CD4+ T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression. Int Immunol (1995) 0.83
A new class of inhibitors of lymphocyte mitogenesis: agents that induce erythroid differentiation in Friend leukemia cells. J Immunol (1980) 0.82
Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia (1994) 0.81
Immunosuppressive properties of polar organic compounds that induce cellular differentiation in Friend erythroleukemia cells. Transplantation (1982) 0.80
Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate. Biochem Biophys Res Commun (1994) 0.80
Induction of alloantigen-specific hyporesponsiveness in vitro by the short-chain fatty acid N-butyrate. Transplantation (1995) 0.79
Induction of alloantigen-specific hyporesponsiveness in vitro by n-butyrate: antagonistic effect of cyclosporin A. Transpl Int (1996) 0.78
T cell clonal anergy. Chem Immunol (1994) 0.77
Immunization against a rat colon carcinoma by sodium butyrate-treated cells but not by interleukin 2-secreting cells. Gastroenterology (1995) 0.77
Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) (2007) 2.92
A microplate assay for the detection of oxidative products using 2',7'-dichlorofluorescin-diacetate. J Immunol Methods (1992) 2.17
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin Exp Immunol (1985) 1.88
Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J (2000) 1.66
Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. Clin Nephrol (2009) 1.51
The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis (2008) 1.42
Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest (2008) 1.32
Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant (2001) 1.20
Acute rhabdomyolysis after atorvastatin and fusidic acid therapy. Am J Med (2000) 1.17
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment. J Clin Immunol (1992) 1.09
Cord blood macrophages present bacterial antigen (Escherichia coli) to paternal T cells. Clin Immunol Immunopathol (1983) 0.97
Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection. Eur J Clin Invest (2005) 0.96
A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T-cell activation. Allergy (2012) 0.94
Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant (2014) 0.94
Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest (2006) 0.91
Human T cell proliferation in response to E. coli presented by autologous macrophages is antigen specific. Clin Exp Immunol (1983) 0.90
CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages. Am J Transplant (2012) 0.90
CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol (1998) 0.90
Gastric mucormycosis due to Rhizopus oryzae in a renal transplant recipient. J Clin Microbiol (1996) 0.89
Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation (1988) 0.89
Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept. Transpl Infect Dis (2009) 0.87
C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol (2001) 0.87
Danon disease: case report and detection of new mutation. J Inherit Metab Dis (2009) 0.86
Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients. Allergy (2014) 0.86
Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1. Allergy (2011) 0.86
Serum proteins modified by neutrophil-derived oxidants as mediators of neutrophil stimulation. J Immunol (2001) 0.86
One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational Study. Transplant Proc (2003) 0.86
Hepatitis C antibody in renal transplant patients. Transplant Proc (1992) 0.85
Co-ligation of CD31 and Fc gamma RII induces cytokine production in human monocytes. J Immunol (1994) 0.85
Autoimmunity and T-cell subpopulations in old age. Arch Gerontol Geriatr (1988) 0.85
Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. J Immunol (1994) 0.84
Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy. Transplant Proc (2007) 0.84
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. Am J Transplant (2007) 0.84
Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational Study. Transplant Proc (2005) 0.84
CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis. Eur J Immunol (2001) 0.83
Enteric-coated mycophenolate sodium reduces gastrointestinal symptoms in renal transplant patients. Transplant Proc (2009) 0.83
Relationship of interferon-gamma and neopterin levels during stimulation with alloantigens in vivo and in vitro. Transplantation (1986) 0.83
Orellanine poisoning: rapid detection of the fungal toxin in renal biopsy material. J Toxicol Clin Toxicol (1997) 0.82
Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial. Am J Transplant (2013) 0.82
The pathophysiologic role of endothelin in acute vascular rejection after renal transplantation. Transplantation (1991) 0.82
Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation. Lancet (1982) 0.82
Pneumonia due to blastomyces dermatitidis in a European renal transplant recipient. Nephrol Dial Transplant (1996) 0.81
Progression of chronic renal failure. Lancet (1988) 0.81
Living on chronic hemodialysis between dryness and fluid overload. Kidney Int Suppl (1997) 0.81
Polymorphonuclear granulocyte stimulation by cellulose-based hemodialysis membranes. Clin Chem Lab Med (1999) 0.81
Stable prodrugs of n-butyric acid: suppression of T cell alloresponses in vitro and prolongation of heart allograft survival in a fully allogeneic rat strain combination. Transpl Immunol (1999) 0.81
Reduced antigen-induced proliferation and surface Ia expression of peripheral blood T cells following tetanus booster immunization. Clin Immunol Immunopathol (1985) 0.81
Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients. Am J Transplant (2008) 0.81
Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J Immunol (2001) 0.80
The malononitrilamide FK778 inhibits activation of NF-kappaB in human dendritic cells. Transplant Proc (2005) 0.80
Is determination of PP 65 useful for early diagnosis of cytomegalovirus infection in renal transplantation? Transplant Proc (1992) 0.80
Cyclosporin A and prednisolone: an additive inhibitory effect of cell proliferation and interleukin-2 production. Transplant Proc (1989) 0.80
C4d deposits in renal allografts are associated with inferior graft outcome. Transplant Proc (2001) 0.80
CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibited. Transplant Proc (2002) 0.79
Novel C5-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes. J Am Soc Nephrol (1999) 0.79
Induction of alloantigen-specific hyporesponsiveness in vitro by the short-chain fatty acid N-butyrate. Transplantation (1995) 0.79
Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic). Clin Nephrol (2006) 0.78
Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient. Nephrol Dial Transplant (1996) 0.78
Induction of alloantigen-specific hyporesponsiveness in vitro by n-butyrate: antagonistic effect of cyclosporin A. Transpl Int (1996) 0.78
Can treatment with the monoclonal antibody BMA031 induce cytokine release? Transplant Proc (1992) 0.78
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? Transplantation (1998) 0.77
Dialysis in diabetic patients: hemodialysis and peritoneal dialysis. Pros and cons. Minerva Urol Nefrol (2012) 0.77
GBV-C/HGV in hemodialysis patients: anti-E2 antibodies and GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells. Kidney Int (1998) 0.77
Post-transplantation diabetes mellitus: evaluation of treatment strategies. Clin Transplant (2015) 0.77
OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patients. Transplant Proc (1989) 0.77
Immunologic monitoring in OKT3-treated kidney graft recipients. Transplant Proc (1990) 0.77
Reactive oxygen product formation after Fc gamma receptor-mediated neutrophil activation by monomeric mouse IgG2a: implications for the generation of first dose effects after OKT3 treatment. Eur J Immunol (1993) 0.77
Complement-dependent acceleration of apoptosis in neutrophils by dialyzer membranes. Kidney Int Suppl (2001) 0.77
Sirolimus and kidney transplantation: unraveling an inflammatory affair. Am J Transplant (2010) 0.77
Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. Am J Kidney Dis (2000) 0.77
Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study. Transplant Proc (2005) 0.76
Suppression of primary T-cell responses and induction of alloantigen-specific hyporesponsiveness in vitro by the Janus kinase inhibitor tyrphostin AG490. Transplantation (2000) 0.76
A functional defect in the early phase of the immune response observed in patients with hemophilia A. Clin Immunol Immunopathol (1986) 0.76
Influence of immunosuppressive therapy on infectious complications in renal transplant recipients. Transplant Proc (1992) 0.76
The diagnosis of posttransplantation diabetes mellitus: meeting the challenges. Curr Diab Rep (2015) 0.76
Targeting the ERK-1/2 signalling pathway results in alloantigen-specific anergy in human T cells. Transplant Proc (2002) 0.76
Broadband ultrasound attenuation of the calcaneus. A tool for assessing bone status in patients with chronic renal failure. Acta Radiol (1998) 0.75
Magic mushrooms: hope for a 'cheap high' resulting in end-stage renal failure. Nephrol Dial Transplant (1996) 0.75
Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes. Clin Exp Immunol (1994) 0.75
How to make clinical use of bacterial evasion strategies. Eur J Clin Invest (2003) 0.75
Synergistic effect of coumarin (1,2 benzopyrone) and endotoxin in the induction of human interleukin-1. Clin Exp Immunol (1991) 0.75
Increased levels of plasma amylin in advanced renal failure. Clin Nephrol (1992) 0.75
Secondary hypersplenism due to Caroli syndrome complicating immunosuppression in a renal allograft recipient. Nephron (1989) 0.75
ATG overdose in a kidney-grafted patient. Clinical course and possible implications. Transpl Int (1988) 0.75